Rescheduling Cannabis: Big Pharma’s Gain, Small Businesses’ Pain—Can the Industry Adapt?

The Chronic Magazine
By Hunter DublinNov 29, 2024, 8:17 am428 ptsTop
As the federal government moves closer to potentially rescheduling cannabis to Schedule III, the industry stands on the brink of a seismic transformation. While the shift could usher cannabis into the pharmaceutical mainstream—potentially landing products on the shelves of CVS and Walgreens—it also poses…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Jones Soda Co. Sells Mary Jones THC Beverage Brand 68

Federal Court Upholds Arkansas Hemp Restrictions, Contradicting Texas Governor’s Stance In Vetoing Proposed Ban In His State 67

Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix 66

Feds Say Tourist Who Admitted To Prior Marijuana Use In Legal Places Was Denied Entry To US Over Drugs—Not Bald JD Vance Meme 63

Chicago Police Can’t Search Vehicles Based on Smell of Raw Cannabis Under New Rules 61

Benzinga Chicago 2025: Event Recap 61

Half-Year Retrospective: What Has Worked and What Hasn’t in Cannabis 60

Why Mitra9 Zero-Proof Wholesale is the Smart Choice For Modern Distributors 56

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.